[HTML] springer.comFull View

[HTML][HTML] Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha, S Siddiqui, A de la Hoz… - Respiratory …, 2020 - Springer
Background Chronic obstructive pulmonary disease (COPD) is characterised by progressive
airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which …
被引用次数：54 相关文章

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

D Singh, JA Wedzicha, S Siddiqui, A de la Hoz… - Respiratory …, 2020 - europepmc.org
Background Chronic obstructive pulmonary disease (COPD) is characterised by progressive
airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which …

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha, S Siddiqui… - Respiratory …, 2020 - discovery.dundee.ac.uk
Background: Chronic obstructive pulmonary disease (COPD) is characterised by
progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD …

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha, S Siddiqui… - Respiratory …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) is characterised by progressive
airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which …

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha, S Siddiqui, A de la Hoz… - Respiratory …, 2020 - go.gale.com
Background Chronic obstructive pulmonary disease (COPD) is characterised by progressive
airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which …
[HTML] biomedcentral.com

[HTML][HTML] Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha… - Respiratory …, 2020 - respiratory-research.biomedcentral …
Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow
limitation and chronic inflammation. Predicting exacerbations of COPD, which contribute to …

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha, S Siddiqui… - Respiratory …, 2020 - search.proquest.com
Background Chronic obstructive pulmonary disease (COPD) is characterised by progressive
airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which …
[HTML] nih.gov

[HTML][HTML] Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha, S Siddiqui, A de la Hoz… - Respiratory …, 2020 - ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) is characterised by progressive
airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which …
[PDF] core.ac.uk

[PDF][PDF] Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha, S Siddiqui, A de la Hoz, W Xue… - 2020 - core.ac.uk
Background: Chronic obstructive pulmonary disease (COPD) is characterised by
progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD …
[PDF] dundee.ac.uk

[PDF][PDF] Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

D Singh, JA Wedzicha, S Siddiqui, A de la Hoz, W Xue… - 2020 - discovery.dundee.ac.uk
Background: Chronic obstructive pulmonary disease (COPD) is characterised by
progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD …